EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA

被引：216
|
作者：
MITCHELL, MS
KEMPF, RA
HAREL, W
SHAU, H
BOSWELL, WD
LIND, S
BRADLEY, EC
机构：
[1] UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90033
[4] CETUS CORP,EMERYVILLE,CA 94608
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 03期
关键词：
D O I：
10.1200/JCO.1988.6.3.409
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：409 / 424
页数：16
相关论文
共 50 条
  • [31] Low-Dose Interleukin-2 and HCV-Induced Vasculitis REPLY
    Saadoun, David
    Cacoub, Patrice
    Klatzmann, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14): : 1354 - 1354
  • [32] The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
    David Klatzmann
    Abul K. Abbas
    Nature Reviews Immunology, 2015, 15 : 283 - 294
  • [33] Low-dose Interleukin-2: Biology and therapeutic prospects in rheumatoid arthritis
    Wu, Ruihe
    Li, Na
    Zhao, Xiangcong
    Ding, Tingting
    Xue, Hongwei
    Gao, Chong
    Li, Xiaofeng
    Wang, Caihong
    AUTOIMMUNITY REVIEWS, 2020, 19 (10)
  • [34] Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
    Zhang, Xia
    Feng, Ruiling
    Shao, Miao
    Wang, Yifan
    Sun, Xiaolin
    He, Jing
    RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1905 - 1914
  • [35] Treatment of metastatic renal cell carcinoma with low-dose interleukin-2
    Takezawa, Yuta
    Izumi, Kouji
    Nohara, Takahiro
    Narimoto, Kazutaka
    Ueno, Satoru
    Kadono, Yoshihumi
    Kitagawa, Yasuhide
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    ANNALS OF ONCOLOGY, 2015, 26 : 145 - 145
  • [36] RESPONSE OF THERAPY-RELATED MYELODYSPLASIA TO LOW-DOSE INTERLEUKIN-2
    TOZE, CL
    BARNETT, MJ
    KLINGEMANN, HG
    LEUKEMIA, 1993, 7 (03) : 463 - 465
  • [37] Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2
    Przepiorka, D
    Jaeckle, KA
    Birdwell, RR
    Fuller, GN
    Kumar, AJ
    Huh, YO
    McCutcheon, I
    BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 983 - 987
  • [38] The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
    Klatzmann, David
    Abbas, Abul K.
    NATURE REVIEWS IMMUNOLOGY, 2015, 15 (05) : 283 - 294
  • [39] Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
    Xia Zhang
    Ruiling Feng
    Miao Shao
    Yifan Wang
    Xiaolin Sun
    Jing He
    Rheumatology and Therapy, 2021, 8 : 1905 - 1914
  • [40] Low-dose interleukin-2 therapy for the treatment of systemic lupus erythematosus
    Humrich, Jens Y.
    Riemekasten, Gabriela
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (02) : 208 - 212
12345